Chronopharmacokinetics and mechanisms of gefitinib in a nude mice model of non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chronopharmacokinetics and mechanisms of gefitinib in a nude mice model of non-small cell lung cancer

Published:2016 Issue:98 Volume:6 Page:95780-95788
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Wang Le¹²³⁴,Li Lujia⁵⁶⁷⁴,Zhao Liyan¹⁶⁷⁴,Liu Changjiao⁸⁹⁴,Liu Jiao¹¹⁰¹¹¹²,Liu Liang¹²³⁴,Lin Pingping¹³¹⁴¹⁵¹⁶⁴,Liu Bo¹⁶⁷⁴,Li Mingchun¹⁶⁷⁴

Affiliation:

1. Department of Pharmacy

2. Pharmaceutical College of Qingdao University

3. Qingdao 266021

4. China

5. Department of Oncology

6. No. 401 Hospital of Chinese People's Liberation Army

7. Qingdao 266071

8. Pharmaceutical College of Dalian Medical University

9. Dalian 116000

10. Affiliate Hospital of Weifang Medical University

11. Weifang

12. 261000 China

13. Department of Clinical Pharmacology

14. Zhongshan Hospital

15. Fudan University

16. Shanghai 200032

Abstract

Circadian rhythms may influence the pharmacokinetics of drugs.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2016/RA/C6RA13854C

Reference32 articles.

2. Epidermal growth factor receptor tyrosine kinase inhibitors in elderly patients with non-small cell lung cancer

3. Smooth-muscle BMAL1 participates in blood pressure circadian rhythm regulation

4. N-glycosylation is essential for ileal ASBT function and protection against proteases

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The past, present, and future of chemotherapy with a focus on individualization of drug dosing;Journal of Controlled Release;2022-12

2. The Evaluation of Animal Models in the Development of Anticancer Agents: From Preclinical to Clinical Tests;Current Cancer Drug Targets;2019-03-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3